- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02433951
Exercise Tolerance in Patients With CABG and Sternotomy vs. Patients With Minimally Invasive Coronary Surgery (ENDO-ACAB)
August 17, 2015 updated by: Dominique Hansen, Hasselt University
Exercise Tolerance in Patients With Coronary Artery Bypass Surgery (CABG) and Sternotomy vs. Patients With Minimally Invasive Coronary Surgery
In this study, up to 20 healthy individuals, 20 endo-ACAB patients, and 20 CABG patients undergo a maximal cardiopulmonary exercise test after hospital discharge (for patients only).
Exercise tolerance is compared between groups.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
In this prospective observational study, up to 20 healthy individuals (no history or presence of any chronic disease, sedentary), 20 endo-ACAB patients, and 20 CABG patients (matched for age, gender and BMI) undergo a maximal cardiopulmonary exercise test after hospital discharge (for patients only).During this exercise test, following parameters are assessed at peak effort and at the second ventilatory threshold (determined by VE/VCO2 slope method): oxygen uptake (VO2), oxygen saturation (SaO2), carbon dioxide output (VCO2), resoiratory gas exchange ratio (RER), expiratory volume (VE), ventilatory equivalent for VCO2 (VE/VCO2), ventilatory equivalent for VO2 (VE/VO2), end-tidal O2 pressure (PETO2), end-tidal CO2 pressure (PETCO2), heart rate (HR), oxygen pulse (VO2/HR), cycling power output (W), tidal volume (Vt), respiratory rate (RR), systolic blood pressure (SBP), diastolic blood pressure (DBP), rate pressure product (RPP).
Peak exercise effort is validated by RERpeak.
Study Type
Observational
Enrollment (Actual)
55
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Hasselt, Belgium, 3500
- Jessa Hospital
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
40 years to 85 years (Adult, Older Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Patients undergoing CABG surgery or endo-ACAB surgery.
Description
Inclusion Criteria:
- undergoing this type of surgery. For healthy subjects: must be sedentary.
Exclusion Criteria:
- any neurologic, nephrologic, respiratory disease. For healthy subjects: any chronic disease or condition.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
healthy individuals
Age, gender and BMI matched healthy subjects without any chronic disease or physical disability, and being sedentary.
|
Maximal exercise test with ergospirometry.
|
|
CABG patients
Age, gender and BMI matched CABG patients, without neurologic, nephrologic, respiratory disease.
|
Maximal exercise test with ergospirometry.
|
|
endo-ACAB patients
Age, gender and BMI matched endo-ACAB patients without neurologic, nephrologic, respiratory disease.
|
Maximal exercise test with ergospirometry.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
VO2peak (peak oxygen uptake)
Time Frame: At peak exercise, single measurement which is executed between 2-4 weeks after surgery.
|
Peak oxygen uptake capacity, expressed as ml/min.
|
At peak exercise, single measurement which is executed between 2-4 weeks after surgery.
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Study Director: Paul Dendale, Jessa Hospital, Stadsomvaart 11, 3500 Hasselt, Belgium
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
February 1, 2015
Primary Completion (Actual)
June 1, 2015
Study Completion (Actual)
July 1, 2015
Study Registration Dates
First Submitted
April 24, 2015
First Submitted That Met QC Criteria
April 29, 2015
First Posted (Estimate)
May 5, 2015
Study Record Updates
Last Update Posted (Estimate)
August 19, 2015
Last Update Submitted That Met QC Criteria
August 17, 2015
Last Verified
August 1, 2015
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- ENDO-ACAB study
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Coronary Artery Bypass Surgery
-
Queen Mary University of LondonRecruitingCoronary Artery Bypass | CABG | Valve Surgery | Coronary Artery Bypass Graft | Cardiovascular | Valve Replacement | Coronary Artery Bypass Graft Surgery (CABG)United Kingdom
-
Baskent UniversityUnknownCoronary Artery Bypass SurgeryTurkey
-
University Hospital Birmingham NHS Foundation TrustUnknownCoronary Artery Bypass SurgeryUnited Kingdom
-
Maria Cecilia HospitalRecruitingCoronary Artery Bypass SurgeryItaly
-
Ajou University School of MedicineNot yet recruitingCoronary Artery Bypass SurgeryKorea, Republic of
-
Universidade do Sul de Santa CatarinaICSCCompleted
-
The Medicines CompanyCompletedCardiac Surgery | Coronary Artery Bypass SurgeryUnited States
-
Università Vita-Salute San RaffaeleCompletedCardiac Surgery | Coronary Artery Bypass Grafting | Aortocoronary BypassCroatia, Italy, China, Malaysia, Russian Federation, Portugal, Bahrain, Brazil, Bulgaria, Czechia, Egypt, Saudi Arabia, Serbia
-
London Health Sciences CentreTerminated
-
Golden Jubilee National HospitalEuropean Society for Intravenous AnaesthesiaUnknownCoronary Artery Bypass SurgeryUnited Kingdom
Clinical Trials on Cardiopulmonary exercise test
-
Academisch Medisch Centrum - Universiteit van Amsterdam...RecruitingFabry Disease | Fabry Disease, Cardiac VariantNetherlands
-
University of HullSheffield Hallam UniversityTerminated
-
Virginia Commonwealth UniversityNovartis PharmaceuticalsCompletedPrior Acute Myocardial Infarction | Evidence of Systemic Inflammation (C Reactive Protein Plasma >2 mg/l) | Reduced Left Ventricle Ejection Fraction (<50%) | Symptoms of Heart Failure (NYHA Class II-III)United States
-
The Clatterbridge Cancer Centre NHS Foundation...University of Liverpool Cancer Research CentreNot yet recruiting
-
York Teaching Hospitals NHS Foundation TrustUniversity of York; York St John UniversityCompletedInflammatory Response | Immune SystemUnited Kingdom
-
Bezmialem Vakif UniversityCompleted
-
Chang Gung Memorial HospitalCompletedComorbid Chronic Lung Disease on Heart Failure
-
Wissenschaftliches Institut Bethanien e.VRoche Pharma AGCompleted
-
Imperial College LondonCompletedHereditary Hemorrhagic Telangiectasia | Pulmonary Arteriovenous MalformationsUnited Kingdom
-
Rambam Health Care CampusRecruiting